United States: Federal Circuit Holds Marketing Of Generic Bioequivalent Can Satisfy Induced Infringement - Pearl Cohen Zedek Latzer Baratz

The U.S. Court of Appeals for the Federal Circuit held that a generic drug manufacturer's marketing of a generic bioequivalent with knowledge and intent ...